| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87a863132c68cf0f62015bbd5d05ab38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2016-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f270fa98909e2f671e29a2d074e843d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a35a613fa230fd6fda5c623bc46873be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58056efaf5eab969cc8291eb40e15f59 |
| publicationDate |
2017-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201735946-A |
| titleOfInvention |
Combination of anti-CD38 antibody and survivin inhibitor in hemoglobin malignant tumor |
| abstract |
The present invention relates to the combination of an anti-CD38 antibody and a survivin inhibitor in a hemoglobin malignancy. |
| priorityDate |
2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |